Correction to: Br J Cancer 10.1038/s41416-022-01713-w, published online 29 January 2022
In this article the author name Sonia Zaibet was incorrectly written as Simon Zaibet. The original article has been corrected.
. 2022 Feb 11;126(6):969. doi: 10.1038/s41416-022-01734-5
Correction to: Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study
Sonia Zaibet
1, Vincent Hautefeuille
2, Edouard Auclin
3,4, Astrid Lièvre
5, David Tougeron
6, Mathieu Sarabi
7, Marine Gilabert
8, Julie Wasselin
2, Julien Edeline
9, Pascal Artru
10, Dominique Bechade
11, Clémence Morin
7, Agnes Ducoulombier
12, Julien Taieb
1, Simon Pernot
11,✉
Sonia Zaibet
1Department of Hepato-Gastroenterology and Gastrointestinal Oncology, Hôpital Européen Georges Pompidou, Université de Paris, SIRIC CARPEM Comprehensive Cancer Center, Paris, France
Find articles by Sonia Zaibet
Vincent Hautefeuille
2Department of Hepato-Gastroenterology and Gastrointestinal Oncology, CHU Amiens Picardie, Amiens, France
Find articles by Vincent Hautefeuille
Edouard Auclin
3Department of Medical Oncology, Hôpital Européen Georges Pompidou, Université de Paris, SIRIC CARPEM Comprehensive Cancer Center, Paris, France
4INSERM, UMR 1138, team 22, Centre de Recherche des Cordeliers, Université de Paris, Paris, France
Find articles by Edouard Auclin
Astrid Lièvre
5Department of Gastroenterology, CHU Rennes, INSERM U1242, Rennes, France
Find articles by Astrid Lièvre
David Tougeron
6Department of Hepato-Gastroenterology, CHU Poitiers, Poitiers, France
Find articles by David Tougeron
Mathieu Sarabi
7Department of Medical Oncology, Centre Léon Bérard, Lyon, France
Find articles by Mathieu Sarabi
Marine Gilabert
8Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France
Find articles by Marine Gilabert
Julie Wasselin
2Department of Hepato-Gastroenterology and Gastrointestinal Oncology, CHU Amiens Picardie, Amiens, France
Find articles by Julie Wasselin
Julien Edeline
9Department of Medical Oncology, Centre Eugène Marquis, Rennes, France
Find articles by Julien Edeline
Pascal Artru
10Department of Hepato-Gastroenterology, Hôpital Privé Jean Mermoz, Lyon, France
Find articles by Pascal Artru
Dominique Bechade
11Department of Medical Oncology, Institut Bergonié, Bordeaux, France
Find articles by Dominique Bechade
Clémence Morin
7Department of Medical Oncology, Centre Léon Bérard, Lyon, France
Find articles by Clémence Morin
Agnes Ducoulombier
12Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France
Find articles by Agnes Ducoulombier
Julien Taieb
1Department of Hepato-Gastroenterology and Gastrointestinal Oncology, Hôpital Européen Georges Pompidou, Université de Paris, SIRIC CARPEM Comprehensive Cancer Center, Paris, France
Find articles by Julien Taieb
Simon Pernot
11Department of Medical Oncology, Institut Bergonié, Bordeaux, France
Find articles by Simon Pernot
1Department of Hepato-Gastroenterology and Gastrointestinal Oncology, Hôpital Européen Georges Pompidou, Université de Paris, SIRIC CARPEM Comprehensive Cancer Center, Paris, France
2Department of Hepato-Gastroenterology and Gastrointestinal Oncology, CHU Amiens Picardie, Amiens, France
3Department of Medical Oncology, Hôpital Européen Georges Pompidou, Université de Paris, SIRIC CARPEM Comprehensive Cancer Center, Paris, France
4INSERM, UMR 1138, team 22, Centre de Recherche des Cordeliers, Université de Paris, Paris, France
5Department of Gastroenterology, CHU Rennes, INSERM U1242, Rennes, France
6Department of Hepato-Gastroenterology, CHU Poitiers, Poitiers, France
7Department of Medical Oncology, Centre Léon Bérard, Lyon, France
8Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France
9Department of Medical Oncology, Centre Eugène Marquis, Rennes, France
10Department of Hepato-Gastroenterology, Hôpital Privé Jean Mermoz, Lyon, France
11Department of Medical Oncology, Institut Bergonié, Bordeaux, France
12Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France
✉
Corresponding author.
Issue date 2022 Apr 1.
Subject terms: Pancreatic cancer, Outcomes research
© The Author(s), under exclusive licence to Springer Nature Limited 2022
PMCID: PMC8927455 PMID: 35149856
This corrects the article "Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study" on page 1394.